A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282
ConditionPrimary Hypercholesterolemia
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age19+
SponsorAddpharma Inc.
About this trial
The purpose of this study is to evaluate the efficacy and safetyof co-administration of AD-2281 and AD-2282 in patients with Primary Hypercholesterolemia
Eligibility criteria
Qualifiers
Signed informed consent
Patients with Primary Hypercholesterolemia
Other inclusions applied
Disqualifiers
Patients with Secondary Hypercholesterolemia
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-2281
- AD-2282
- Placebo of AD-2282
Treatment groups
110 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov